ArticleCanadian journal of gastroenterology = Journal canadien de gastroenterologie2007
Management of chronic hepatitis C: consensus guidelines.
Article in Canadian journal of gastroenterology = Journal canadien de gastroenterologie, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01095445 (EXtended Therapy in Genotype 3 Infected Patients Who do Not AChieve a Treatment Response at Week 4), which is not on this map. Cited by 54 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
EXtended Therapy in Genotype 3 Infected Patients Who do Not AChieve a Treatment Response at Week 4 (RVR) But do Achieve a Complete Early Virologic Response (cEVR)
Who cites it
54 citing papers in PubMed, 1 synthesis or guideline pooled it, 141 citations in OpenAlex.
- An update on the management of hepatitis C: consensus guidelines from the Canadian Association for the Study of the Liver.Canadian journal of gastroenterology = Journal canadien de gastroenterologie · 2012Guideline
- Safety and efficacy of Hansenula-derived PEGylated-interferon alpha-2a and ribavirin combination in chronic hepatitis C Egyptian children.World journal of gastroenterology · 2014Trial
- Adherence to treatment for recently acquired hepatitis C virus (HCV) infection among injecting drug users.Journal of hepatology · 2011Trial
- Trends in chronic hepatitis C visits by providers in Quebec, Canada: A population-level cohort study.Canadian liver journal · 2026Article
- Characterizing the cascade of care for hepatitis C virus infection among Status First Nations peoples in Ontario: a retrospective cohort study.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2023Article
- A Real-World Study to Compare the Safety and Efficacy of Paritaprevir/Ombitasvir/Ritonavir and Dasabuvir, with or without Ribavirin, in 587 Patients with Chronic Hepatitis C at the Fundeni Clinical Institute, Bucharest, Romania.Medical science monitor : international medical journal of experimental and clinical research · 2022Observational
- Characterizing risk behaviour and reinfection rates for successful programs to engage core transmitters in HCV elimination (C-RESPECT).Canadian liver journal · 2021Article
- Assessing State Variation in Plastic Surgeons' Risk of Hepatitis C Exposure: Revisit in Methodology.Plastic and reconstructive surgery. Global open · 2020Article
- Prevalence and genotyping pattern of hepatitis C virus among patients on maintenance hemodialysis at five centers in Pune, India.Medical journal, Armed Forces India · 2019Article
- Let's Talk About B: Barriers to Hepatitis B Screening and Vaccination Among Asian and South Asian Immigrants in British Columbia.Journal of racial and ethnic health disparities · 2018Article
- Real-world effectiveness of peginterferon α-2b plus ribavirin in a Canadian cohort of treatment-naïve chronic hepatitis C patients with genotypes 2 or 3: results of the PoWer and RediPEN studies.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2016Observational
- Cost-effectiveness of screening for hepatitis C in Canada.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2015Article
- Hepatitis C surveillance in Canada.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2014Article
- Eligibility of persons who inject drugs for treatment of hepatitis C virus infection.World journal of gastroenterology · 2014Review
- Association of Hepatitis C Virus Infection and Interleukin-28B Gene Polymorphism in Chinese Children.Pakistan journal of medical sciences · 2014Article
- Chronic hepatitis C in Western Canada: a survey of practice patterns among gastroenterologists in Alberta and British Columbia.Canadian journal of gastroenterology & hepatology · 2014Article
- The metabolomic window into hepatobiliary disease.Journal of hepatology · 2013Review
- The epidemiology of hepatitis C in a Canadian Indigenous population.Canadian journal of gastroenterology = Journal canadien de gastroenterologie · 2013Article
- Hepatitis C and the surgeon.Canadian journal of surgery. Journal canadien de chirurgie · 2013Article
- The role of eltrombopag in the management of hepatitis C virus-related thrombocytopenia.Hepatic medicine : evidence and research · 2013Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 6 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Since the last consensus conference on the management of chronic viral hepatitis, a number of studies looking at modifications of the standard course of treatment have been published. These changes have been sufficiently substantive to warrant review to determine whether any changes in the recommended treatment algorithms are needed. A consensus development conference was held in January 2007, and the present document highlights the results of the presentations and discussion about these issues. It reviews the epidemiology of hepatitis C in Canada, treatment of acute hepatitis C and new algorithms in chronic hepatitis C, including retreatment of previous treatment failures. In addition, sections on management of hepatitis C in special populations have been updated. There is also a section on the use of hematopoietic growth factors to help manage patients on therapy. The document should be read in conjunction with the previous document to identify changes. Some recommendations made in the previous document remain and are not discussed here.
Indexed as
Identifiers
17568824PMC2794457W2129683974What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.